Status: current, Defined. Date: 31-Mar 2014. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2966971000168112 | Liposomal Doxorubicin (Sun) (doxorubicin hydrochloride (as pegylated liposomal) 50 mg / 25 mL) injection, 25 mL vial (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 2966981000168110 | Liposomal Doxorubicin (Sun) 50 mg/25 mL injection, 25 mL vial | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Liposomal Doxorubicin (Sun) 50 mg/25 mL injection, 25 mL vial | has manufactured dose form | injection | true | Inferred relationship | Some | ||
| Liposomal Doxorubicin (Sun) 50 mg/25 mL injection, 25 mL vial | Is a | trade product unit of use | true | Inferred relationship | Some | ||
| Liposomal Doxorubicin (Sun) 50 mg/25 mL injection, 25 mL vial | Is a | Liposomal Doxorubicin (Sun) | true | Inferred relationship | Some | ||
| Liposomal Doxorubicin (Sun) 50 mg/25 mL injection, 25 mL vial | Is a | doxorubicin hydrochloride (as pegylated liposomal) 50 mg/25 mL injection, vial | true | Inferred relationship | Some | ||
| Liposomal Doxorubicin (Sun) 50 mg/25 mL injection, 25 mL vial | has manufactured dose form | concentrated injection | false | Inferred relationship | Some | ||
| Liposomal Doxorubicin (Sun) 50 mg/25 mL injection, 25 mL vial | has intended active ingredient | doxorubicin hydrochloride (as pegylated liposomal) | true | Inferred relationship | Some | 1031272190 | |
| Liposomal Doxorubicin (Sun) 50 mg/25 mL injection, 25 mL vial | has Australian BoSS | doxorubicin hydrochloride (as pegylated liposomal) | true | Inferred relationship | Some | 1031272190 | |
| Liposomal Doxorubicin (Sun) 50 mg/25 mL injection, 25 mL vial | has unit of use | vial | true | Inferred relationship | Some | 1031272191 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Liposomal Doxorubicin (Sun) 50 mg/25 mL injection, 25 mL vial | has TPUU | True | Liposomal Doxorubicin (Sun) 50 mg/25 mL injection, 25 mL vial | Inferred relationship | Some | 1 |
| Liposomal Doxorubicin (Sun) 50 mg/25 mL injection, 25 mL vial | has TPUU | True | Liposomal Doxorubicin (Sun) 50 mg/25 mL injection, 25 mL vial | Inferred relationship | Some | 1 |
Reference Sets
Trade product unit of use reference set
FHIR